1. 首頁 > 生活雜燴 > 健康養生 > >

羅米|中國首個抗新冠「特效藥」為何能頂住奧密克戎的“突襲”？丨奇點深度( 三 )

密克研究特效藥抗體位點安巴突襲羅米司韋單抗深度組合安巴韋羅米

總的來說 ， 從現有的研究來看 ，安巴韋單抗和羅米司韋單抗結合于RBD的兩個完全不同、且互不干擾的位點 ， 這讓它們實現了真正的功能互補 。 另外 ， 患者治療后的 超高血藥濃度以及更高的肺部抗體濃度 ， 也對安巴韋單抗/羅米司韋單抗對目前已知的所有變異株保持中和活性助力不小 。
據了解 ， 清華大學張林琦團隊關于安巴韋單抗/羅米司韋單抗中和奧密克戎的研究即將發表 ， 期待張教授給我們帶來更全面的解答 。
參考文獻：
[2].https://www.krisp.org.za/manus/25Nov2021_B.1.1.529_Media.pdf
[3].Cao Y R, Wang J, Jian F, et al. B. 1.1. 529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes[J]. BioRxiv, 2021.
[4].https://mp.weixin.qq.com/s/48JorUncaQ_isz07rBpVPw
[5].Liu L, Iketani S, Guo Y, et al. Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2[J]. nature, 2021.
[6].Baum A, Fulton B O, Wloga E, et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies[J]. Science, 2020, 369(6506): 1014-1018.
[7].Piccoli L, Park Y J, Tortorici M A, et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology[J]. Cell, 2020, 183(4): 1024-1042. e21.
[8].Corti D, Purcell L A, Snell G, et al. Tackling COVID-19 with neutralizing monoclonal antibodies[J]. Cell, 2021.
[9].Pinto D, Park Y J, Beltramello M, et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody[J]. Nature, 2020, 583(7815): 290-295.
[10].Ge J, Wang R, Ju B, et al. Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry. Nat Commun. 2021;12(1):250. Published 2021 Jan 11.
[11]. Baum A, Fulton B O, Wloga E, et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies[J]. Science, 2020, 369(6506): 1014-1018.
[12].Lempp FA, Soriaga LB, Montiel-Ruiz M, et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021;598(7880):342-347.
[13].https://opendata.ncats.nih.gov/variant/activity
[14].Zhang Y, Hao X, Ma J, et al. Phase 1 safety and pharmacokinetics studies of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies[J]. medRxiv, 2021.
[16].Shah DK, Betts AM. Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human. MAbs. 2013;5(2):297-305. doi:10.4161/mabs.23684
本文作者丨BioTalker